<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01491425</url>
  </required_header>
  <id_info>
    <org_study_id>C-9803</org_study_id>
    <nct_id>NCT01491425</nct_id>
  </id_info>
  <brief_title>A Pivotal Study of rhBMP-2/ACS/LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Degenerative Disc Disease</brief_title>
  <official_title>A Clinical Investigation of Recombinant Human Bone Morphogenetic Protein-2 and Absorbable Collagen Sponge With the LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Symptomatic Degenerative Disc Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medtronic Spinal and Biologics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medtronic Spinal and Biologics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to assess the safety and effectiveness of the rhBMP-2/ACS/LT-CAGE®&#xD;
      Device using laparoscopic surgical technique as compared to an historical control group&#xD;
      treated with Autogenous Bone/LT-CAGE® Device using an open surgical technique in patients&#xD;
      with symptomatic degenerative disc disease.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 1998</start_date>
  <completion_date type="Actual">October 2002</completion_date>
  <primary_completion_date type="Actual">October 2002</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Success</measure>
    <time_frame>24 month</time_frame>
    <description>A patient will be considered an overall success if all of the following conditions are met:&#xD;
fusion;&#xD;
pain/disability (Oswestry) improvement;&#xD;
maintenance or improvement in neurological status;&#xD;
no serious adverse event classified as implant associated or implant/surgical procedure associated;&#xD;
no additional surgical procedure classified as a &quot;failure.&quot;</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Disc Height Measurement</measure>
    <time_frame>24 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General Health Status (SF-36)</measure>
    <time_frame>24 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Status (Numerical Rating Scale)</measure>
    <time_frame>24 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction</measure>
    <time_frame>24 month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Global Perceived Effect</measure>
    <time_frame>24 month</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">134</enrollment>
  <condition>Degenerative Disc Disease</condition>
  <arm_group>
    <arm_group_label>rhBMP-2/ACS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Autogenous Bone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The control group of patients from another study (Protocol ID: C-9702 Pivotal Study of rhBMP-2/ACS/LT-CAGE® Device for Anterior Lumbar Interbody Fusion in Patients With Symptomatic DDD).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>rhBMP-2/ACS//LT-CAGE® Device</intervention_name>
    <description>LT-CAGE® device with recombinant human bone morphogenetic protein-2 ( rhBMP-2) and the absorbable collagen sponge (ACS).</description>
    <arm_group_label>rhBMP-2/ACS</arm_group_label>
    <other_name>Recombinant human bone morphogenetic protein-2</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Autogenous Bone//LT-CAGE® Device</intervention_name>
    <description>LT-CAGE® device with autogenous bone taken from the iliac crest.</description>
    <arm_group_label>Autogenous Bone</arm_group_label>
    <other_name>Autograft</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Has degenerative disc disease as noted by back pain of discogenic origin, with or&#xD;
             without leg pain, with degeneration of the disc confirmed by patient history (&#xD;
             e.g.,pain [leg, back, or symptoms in the sciatic nerve distribution], function deficit&#xD;
             and/or neurological deficit)and radiographic studies ( e.g., CT, MRl, X-Ray, etc.) to&#xD;
             include one or more of the following:&#xD;
&#xD;
               -  instability( defined as angular motion &gt; 5° and/or translation &gt;= 2-4mm, based on&#xD;
                  Flex/Ext radiographs);&#xD;
&#xD;
               -  osteophyte formation;&#xD;
&#xD;
               -  decreased disc height;&#xD;
&#xD;
               -  thickening of ligamentous tissue;&#xD;
&#xD;
               -  disc degeneration or herniation; and/or&#xD;
&#xD;
               -  facet joint degeneration.&#xD;
&#xD;
          2. Has preoperative Oswestry score &gt; 35.&#xD;
&#xD;
          3. Has no greater than Grade 1 spondylolisthesis utilizing Meyerding's Classification&#xD;
             (Meyerding HW, 1932.).&#xD;
&#xD;
          4. Has single-level symptomatic degenerative involvement from L4 to S1.&#xD;
&#xD;
          5. Is at least 18 years of age, inclusive, at the time of surgery.&#xD;
&#xD;
          6. Has not responded to non-operative treatment (e.g., bed rest, physical therapy,&#xD;
             medications, spinal injections, manipulation, and/or TENS) for a period of at least 6&#xD;
             months.&#xD;
&#xD;
          7. If female of child-bearing potential, who is not pregnant or nursing, and who agrees&#xD;
             to use adequate contraception for 16 weeks following surgery.&#xD;
&#xD;
          8. Is willing and able to comply with the study plan and sign the Patient Informed&#xD;
             Consent Form.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Had previous anterior spinal fusion surgical procedure at the involved level.&#xD;
&#xD;
          2. Has posterior spinal instrumentation (which will not be removed) stabilizing the&#xD;
             involved level or has had a previous posterior lumbar interbody fusion procedure at&#xD;
             the involved level.&#xD;
&#xD;
          3. Has a condition which requires postoperative medications that interfere with fusion,&#xD;
             such as steroids.&#xD;
&#xD;
          4. Has been previously diagnosed with osteopenia, osteoporosis, or osteomalacia to a&#xD;
             degree that spinal instrumentation would be contraindicated.&#xD;
&#xD;
          5. Has presence of active malignancy.&#xD;
&#xD;
          6. Has overt or active bacterial infection, either local or systemic.&#xD;
&#xD;
          7. Is grossly obese, i.e., weight &gt; 40% over ideal for their age and height.&#xD;
&#xD;
          8. Has fever ( temperature &gt; 101° F oral) at the time of surgery.&#xD;
&#xD;
          9. Has a documented titanium alloy allergy or intolerance.&#xD;
&#xD;
         10. Is mentally incompetent. if questionable, obtain psychiatric consult.&#xD;
&#xD;
         11. Has a Waddell Signs of Inorganic Behavior score of 3 or greater.&#xD;
&#xD;
         12. Is a prisoner.&#xD;
&#xD;
         13. Is an alcohol and/or drug abuser as defined by currently undergoing treatment for&#xD;
             alcohol and/or drug usage.&#xD;
&#xD;
         14. Is a tobacco user at the time of surgery.&#xD;
&#xD;
         15. Has received drugs which may interfere with bone metabolism within two weeks prior to&#xD;
             the planned date of spinal fusion surgery (e.g., steroids or methotrexate).&#xD;
&#xD;
         16. Has a history of autoimmune disease (Systemic Lupus Erythematosus or Dermatomyositis).&#xD;
&#xD;
         17. Has a history of exposure to injectable collagen implants.&#xD;
&#xD;
         18. Has a history of hypersensitivity to protein pharmaceuticals (monoclonal antibodies or&#xD;
             gamma globulins) or collagen.&#xD;
&#xD;
         19. Has received treatment with an investigational therapy within 28 days prior to&#xD;
             implantation surgery or such treatment is planned during the 16 weeks following&#xD;
             rhBMP-2/ACS implantation.&#xD;
&#xD;
         20. Has received any previous exposure to any/all BMP's of either human or animal&#xD;
             extraction.&#xD;
&#xD;
         21. Has a history of allergy to bovine products or a history of anaphylaxis.&#xD;
&#xD;
         22. Has history of endocrine or metabolic disorder known to affect osteogenesis (e.g.,&#xD;
             Paget's disease, renal osteodystrophy, Ehlers- Danlos syndrome, or osteogenesis&#xD;
             imperfecta).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>December 2011</verification_date>
  <study_first_submitted>December 12, 2011</study_first_submitted>
  <study_first_submitted_qc>December 13, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 14, 2011</study_first_posted>
  <last_update_submitted>August 1, 2013</last_update_submitted>
  <last_update_submitted_qc>August 1, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 2, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>symptomatic degenerative disc disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Diseases</mesh_term>
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

